Stents, Peripheral

Cath Lab

Stents, Peripheral

SMART Vascular Stent Systems Receive FDA Approval for Use in SFA

Cordis Corp. announced that the U.S. Food and Drug Administration (FDA) has approved the S.M.A.R.T. Control Vascular Stent Systems for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery (PPA). The S.M.A.R.T. Stent, wh...

FDA Clears First Drug-Eluting, Self-Expanding Stent for SFA

The U.S. Food and Drug Administration (FDA) granted market clearance for Cook Medical’s Zilver PTX drug-eluting peripheral stent. It is the first device of its kind on several fronts to go before FDA review. It is the first drug-eluting stent...

FDA Clears Omnilink Elite Vascular Balloon-Expandable Stent for Iliac Artery Lesions

Aug. 8, 2012 — The U.S. Food and Drug Administration (FDA) approved the Abbott’s Omnilink Elite Vascular Balloon-Expandable Stent System for the treatment of iliac artery disease. This form of peripheral artery disease (PAD) th...

FDA Clears Boston Scientific’s Epic Self-Expanding Peripheral Stent

May 23, 2012 -- Boston Scientific Corp. announces U.S. Food and Drug Administration approval and market launch of the Epic Vascular Self-Expanding Stent System. The Epic Stent is designed to open blocked arteries in patients with iliac artery sten...

Cordis Acquires Flexible Stenting Solutions
Cordis Corp. announced it has completed the acquisition of Flexible Stenting Solutions Inc., whose technology provides Cordis with the opportunity to evolve...
Biotronik BIOFLEX-I IDE Clinical Trial Puslar-18 Peripheral Artery Disease
Biotronik Announces First U.S. Pulsar-18 Implant in BIOFLEX...
Biotronik announced the first U.S. implant of their Pulsar-18 self expanding stent in the BIOFLEX-I IDE clinical trial. Carlos Mena of Yale University Medical...
FSS Introduces Stent Delivery Technology for...
December 26, 2012 — Flexible Stenting Solutions Inc. (FSS) announced it gained CE mark in the European Union for its 6 French Reconstrainable ...
SFA Stents Show Acceptable Long Term Patency
More than half of patients treated for claudication or critical limb ischemia (CLI) with stenting of the superficial femoral artery (SFA) had primary patency...
PAD Treatment Devices Stent Peripheral Cordis Corp. S.M.A.R.T., SMART, SFA stent
S.M.A.R.T. Control Vascular Stent System for (SFA) and/or (PPA) Use
Cordis Corporation's  S.M.A.R.T. Control Vascular Stent Systems are designed for use in the superficial femoral artery (SFA) and/or
Zilver PTX is First Drug-Eluting Peripheral Stent
Cook Medical’s Zilver PTX drug-eluting peripheral stent is the first device of its kind on several fronts to go before FDA review...
Omnilink Elite Stent Offers Balloon-Expandable Option for Iliac Lesions
The Abbott Omnilink Elite Vascular Balloon-Expandable Stent System is indicated for the treatment of iliac artery lesions with...
Boston Scientific's Epic Vascular Self-Expanding Stent System is designed to open blocked arteries in patients with iliac artery stenosis,...
View All »

Articles

First U.S. Patient Treated with Cook Medical’s Zilver PTX...
January 16, 2013 — Just weeks after the Food and Drug Administration (FDA) approved Cook Medical’s Zilver PTX drug-eluting peripheral stent,...
Cook, Zilver PTX, stent
FDA Clears First Drug-Eluting, Self-Expanding Stent for SFA
The U.S. Food and Drug Administration (FDA) granted market clearance for Cook Medical’s Zilver PTX drug-eluting peripheral stent. It is the first device...
FDA Clears Omnilink Elite Vascular Balloon-Expandable Stent...
Aug. 8, 2012 — The U.S. Food and Drug Administration (FDA) approved the Abbott’s Omnilink Elite Vascular Balloon-Expandable Stent System for the...
FDA Panel Gives Unanimous Nod to Cook Medical’s Zilver PTX...
A U.S. Food and Drug Administration (FDA) review panel has given its unanimous recommendation for the market approval of the Zilver PTX stent. It is the first...

Video Center

view all Videos »

The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
11 weeks 2 days ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
15 weeks 4 days ago
Innovation Exasperation
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
19 weeks 2 days ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...